Terms: = Cervical cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Prognosis
8 results:
1. cervical cancer survival times in Africa.
Drokow EK; Fangninou FF; Effah CY; Agboyibor C; Zhang Y; Arboh F; Deku MA; Xinyin W; Wang Y; Sun K
Front Public Health; 2022; 10():981383. PubMed ID: 36438301
[TBL] [Abstract] [Full Text] [Related]
2. A novel lncRNA-mRNA-miRNA signature predicts recurrence and disease-free survival in cervical cancer.
Li M; Tian X; Guo H; Xu X; Liu Y; Hao X; Fei H
Braz J Med Biol Res; 2021; 54(11):e11592. PubMed ID: 34550275
[TBL] [Abstract] [Full Text] [Related]
3. Screening and Discovery of New Potential Biomarkers and Small Molecule Drugs for cervical cancer: A Bioinformatics Analysis.
Qiu HZ; Huang J; Xiang CC; Li R; Zuo ED; Zhang Y; Shan L; Cheng X
Technol Cancer Res Treat; 2020; 19():1533033820980112. PubMed ID: 33302814
[TBL] [Abstract] [Full Text] [Related]
4. Genetic markers and phosphoprotein forms of beta-catenin pβ-Cat552 and pβ-Cat675 are prognostic biomarkers of cervical cancer.
Scholl SM; Beal J; de Koning L; Girard E; Popovic M; de la Rochefordière A; Lecuru F; Fourchotte V; Ngo C; Floquet A; Berns EM; Kenter G; Gestraud P; von der Leyen H; Lecerf C; Puard V; Roman SR; Latouche A; Kereszt A; Balint B; Rouzier R; Kamal M
EBioMedicine; 2020 Nov; 61():103049. PubMed ID: 33096476
[TBL] [Abstract] [Full Text] [Related]
5. Comparative study on the oncological prognosis of laparoscopy and laparotomy for stage IIA1 cervical squamous cell carcinoma.
Chen C; Fang Z; Wang Q; Li W; Li P; Wang L; Kang S; Zhu B; Lin Z; Wang X; Wang L; Fan H; Bin X; Lang J; Liu P
Eur J Surg Oncol; 2021 Feb; 47(2):346-352. PubMed ID: 32859433
[TBL] [Abstract] [Full Text] [Related]
6. Radiomic analysis for preoperative prediction of cervical lymph node metastasis in patients with papillary thyroid carcinoma.
Lu W; Zhong L; Dong D; Fang M; Dai Q; Leng S; Zhang L; Sun W; Tian J; Zheng J; Jin Y
Eur J Radiol; 2019 Sep; 118():231-238. PubMed ID: 31439247
[TBL] [Abstract] [Full Text] [Related]
7. cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
Cho SY; Choi M; Ban HJ; Lee CH; Park S; Kim H; Kim YS; Lee YS; Lee JY
Oncotarget; 2017 Jan; 8(5):8095-8104. PubMed ID: 28042953
[TBL] [Abstract] [Full Text] [Related]
8. Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.
Spaans VM; Trietsch MD; Crobach S; Stelloo E; Kremer D; Osse EM; Haar NT; van Eijk R; Muller S; van Wezel T; Trimbos JB; Bosse T; Smit VT; Fleuren GJ
PLoS One; 2014; 9(3):e93451. PubMed ID: 24671188
[TBL] [Abstract] [Full Text] [Related]